Trial intelligence / Profile preview

Influence of Prior Chemotherapy on Erlotinib Efficacy in NSCLC

NCT01204307Phase 2Completed

Sponsor
Chang Gung Memorial Hospital
Start
Jan 2010
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of docetaxel in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Chang Gung Memorial Hospital. Started Jan 2010; status: completed.

02

Drugs

docetaxel
03

Conditions

Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)

Beyond the preview

Go deeper on NCT01204307.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01204307.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call